Key result
Long-term enalapril linked to reversible angioedema after 66 months of therapy in a case report.
Case Report (n=1)
This case highlights that ACE inhibitor-induced angioedema can occur unexpectedly even after years of uncomplicated long-term therapy.
May prompt vigilance for late angioedema on ACE inhibitors; leaves open true incidence and risk factors.
We describe a rare case of ACE inhibitor-induced angioedema during long-term therapy in a 51-year-old male patient with essential hypertension; and this is the third case reported of this adverse reaction in Japan. The patient received enalapril for 66 months, and complained of a dry cough which was mild and tolerable. Recently, he noted tenderness of his mouth, face, swelling of lips and tongue for 3 to 4 h after taking his morning dose of enalapril. These symptoms abated spontaneously, so he continued taking the drugs. He again noted similar episodes of angioedema 29 days after the first experience. He had no further episodes of angioedema or dry cough after cessation of enalapril. This case of angioedema developed during long-term therapy with enalapril administered as 19,930 mg of enalapril maleate. We emphasize that angioedema may occur at any time during the use of enalapril.
No takes yet. Share an insight, caveat, or question.
Shionoiri et al. (1996) conducted a case report in Essential hypertension (n=1). Enalapril was evaluated on Angioedema. Long-term enalapril therapy (66 months) induced angioedema in a 51-year-old male patient, which resolved upon cessation of the drug.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: